1Fantanini G, Bigini D, Vinnati S, et al. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol,1995,177:57.
2Ohta Y, Shridhar V.Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma. Cancer, 1999,85:2570-2576.
3Yao L, Zhao Y. Tnrombospondin-1 expression in oral squamous cell carcinomas: correlations with tumor vascularity, clinicopathological features and survival. Oral Oncol, 2000,36:539-544.
3Sandlund J, Hedberg Y, Bergh A, et al. Evaluation of CD31 (PECAM-1)expression using tissue microarray in patients with renal cell carcinoma. Tumour Biol, 2007, 28:158-164.
4Des Guetz G, Uzzan B, Nicolas P, et al. Microvessel density and VEGF expression are prognostic factors in colorectal cancer: meta- analysis of the literature. Br J Cancer, 2006, 94:1823-1832.
5Sabo E, Boltenko A, Sova Y, et al. Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res, 2001, 7:533-537.
6Imao T, Egawa M, Takashima H, et al. Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma. Int J Urol, 2004, 11:948-953.
7Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 1995, 147:9-19.
8Shchors K, Evan G. Tumor angiogenesis: cause or consequence of cancer? Cancer Res, 2007, 67:7059-7061.
9Maclennan GT, Bostwick DG. Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology, 1995, 46: 27-30.
10Thielemann A, Kopczyflski Z, Filas V, et al. The determination of VEGF and MVD, among patients with primary breast cancer. Pathnl Oncol Res, 2008, 14 : 137-144.
